表紙
市場調查報告書
商品編碼
824094

腳踝全置換術的全球市場:成長,趨勢,預測(2019∼2024年)

Total Ankle Replacement Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球腳踝全置換術市場,預計至2024年將以6.3%的年複合成長率擴大。高齡化和風濕,骨關節炎的罹患率上升等成為主要原因。

本報告提供全球腳踝全置換術市場相關調查,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊彙整。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場趨勢

  • 市場概要
  • 推動市場的要素
    • 高齡化
    • 骨關節炎,類風濕性關節炎的罹患率上升
  • 阻礙市場的要素
    • 腳踝全置換手術相關風險
  • 波特五力分析

第5章 市場區隔

  • 各種設計
    • HINTEGRA
    • Scandinavian
    • Salto
    • BOX
    • Zenith
    • Mobility
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭趨勢

  • 企業簡介
    • DePuy Synthes
    • Integra LifeSciences
    • Stryker Corporation
    • Wright Medical Group Inc.
    • MatOrtho
    • Zimmer Holdings

第7章 市場機會與未來趨勢

目錄
Product Code: 57312

The total ankle replacement market is majorly driven by the aging population and the increasing prevalence of rheumatoid and osteoarthritis diseases. According to the Centers for Disease Control and Prevention, with the aging US population, the prevalence of doctor-diagnosed arthritis is expected to increase and by 2040, an estimated 78.4 million (25.9% of the projected total adult population) adults aged 18 years and above are likely to have doctor-diagnosed arthritis.

In the United States, osteoarthritis affects 14% of adults aged 25 years and above and 34% of those aged 65 years and above. It is also estimated that 1.5 million adults are suffering from rheumatoid arthritis, while 3.0 million adults are suffering from gout in the country. An estimated 2, 94,000 children of age 18 years or below (or one in every 250 children) have been diagnosed with arthritis or another rheumatologic condition in the United States. Hence, the increasing number of cases of osteoarthritis and rheumatoid arthritis in adults and children is likely to increase the demand for total ankle replacement surgeries.

Key Market Trends

HINTEGRA Total Ankle Replacement Segment is Expected to Register a Robust Growth

The HINTEGRA total ankle replacement (TAR) was designed by Beat Hintermann, Greta Dereymaeker, Ramon Viladot, and Patrice Diebold, in 2000. It is an unconstrained, three-component system that provides inversion-eversion stability. The HINTEGRA TAR consists of two metallic components and an ultrahigh-density polyethylene mobile bearing, which provide axial rotation and normal flexion-extension mobility.

Furthermore, TAR has evolved as a valuable gold standard treatment option for patients with end-stage ankle osteoarthritis, which generally affects the aging population. Hence, owing to the higher preference of these devices and the rapidly aging population, the market is expected to witness rapid growth in the forecast period.

The United States is Expected to Dominate the Total Ankle Replacement Market

The United States dominates the total ankle replacement market, owing to high awareness among the people and availability of reimbursements. However, Asia-Pacific is predicted to be the emerging region in the total ankle replacement market during the forecast period, due to increasing healthcare expenditure and rising awareness regarding innovative medical technologies.

Competitive Landscape

Globally, only a few major players control the major share of the market studied, which is primarily due to the need for high technological expertise in the development of devices and regulatory challenges involved in the development of total ankle replacement devices. Key market players include Johnson & Johnson, Integra LifeSciences Corporation, Stryker Corporation, Wright Medical Group Inc., MatOrtho, Zimmer Biomet, Exactech Inc., and Corin Group.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population
    • 4.2.2 Growing Prevalence of Osteoarthritis and Rheumatoid Arthritis
  • 4.3 Market Restraints
    • 4.3.1 Risks Associated with Total Ankle Replacement Surgery
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Design
    • 5.1.1 HINTEGRA Total Ankle Replacement
    • 5.1.2 Scandinavian Total Ankle Replacement
    • 5.1.3 Salto Total Ankle Replacement
    • 5.1.4 BOX Total Ankle Replacement
    • 5.1.5 Zenith Total Ankle Replacement
    • 5.1.6 Mobility Total Ankle Replacement
    • 5.1.7 Other Designs
  • 5.2 By Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Johnson & Johnson
    • 6.1.2 Integra LifeSciences Corporation
    • 6.1.3 Stryker Corporation
    • 6.1.4 Wright Medical Group Inc.
    • 6.1.5 MatOrtho
    • 6.1.6 Zimmer Biomet
    • 6.1.7 Exactech Inc.
    • 6.1.8 Corin Group

7 MARKET OPPORTUNITIES AND FUTURE TRENDS